Svf Investments (uk) Ltd - Net Worth and Insider Trading

Svf Investments (uk) Ltd Net Worth

The estimated net worth of Svf Investments (uk) Ltd is at least $9.4 Billion dollars as of 2024-11-13. Svf Investments (uk) Ltd is the 10% Owner of Coupang Inc and owns about 349,542,259 shares of Coupang Inc (CPNG) stock worth over $8.6 Billion. Svf Investments (uk) Ltd is the 10% Owner of Roivant Sciences Ltd and owns about 73,031,667 shares of Roivant Sciences Ltd (ROIV) stock worth over $850 Million. Svf Investments (uk) Ltd is also the 10% Owner of Sio Gene Therapies Inc and owns about 13,244,048 shares of Sio Gene Therapies Inc (SIOX) stock worth over $6 Million. Details can be seen in Svf Investments (uk) Ltd's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Svf Investments (uk) Ltd has not made any transactions after 2024-03-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data on One Screen
Unlimited Filters in All-in-One Stock Screener
Exclusive Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Downloadable Data
Quick Customer Support
And Much More...

Transaction Summary of Svf Investments (uk) Ltd

To

Svf Investments (uk) Ltd Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Svf Investments (uk) Ltd owns 6 companies in total, including Arbutus Biopharma Corp (ABUS) , Sio Gene Therapies Inc (SIOX) , and Myovant Sciences Ltd (MYOV) among others .

Click here to see the complete history of Svf Investments (uk) Ltd’s form 4 insider trades.

Insider Ownership Summary of Svf Investments (uk) Ltd

Ticker Comapny Transaction Date Type of Owner
ABUS Arbutus Biopharma Corp 2017-09-06 10 percent owner
SIOX Sio Gene Therapies Inc 2019-03-18 10 percent owner
MYOV Myovant Sciences Ltd 2017-09-06 10 percent owner
LIMIT LIMIT 2019-07-10 other: Former 10% Owner
LIMIT LIMIT 2023-09-28 10 percent owner
LIMIT LIMIT 2024-03-13 10 percent owner

Svf Investments (uk) Ltd Latest Holdings Summary

Svf Investments (uk) Ltd currently owns a total of 3 stocks. Among these stocks, Svf Investments (uk) Ltd owns 349,542,259 shares of Coupang Inc (CPNG) as of March 13, 2024, with a value of $8.6 Billion and a weighting of 90.91%. Svf Investments (uk) Ltd owns 73,031,667 shares of Roivant Sciences Ltd (ROIV) as of September 28, 2023, with a value of $850 Million and a weighting of 9.02%. Svf Investments (uk) Ltd also owns 13,244,048 shares of Sio Gene Therapies Inc (SIOX) as of March 18, 2019, with a value of $6 Million and a weighting of 0.07%.

Latest Holdings of Svf Investments (uk) Ltd

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
CPNG Coupang Inc 2024-03-13 349,542,259 24.51 8,567,280,768
ROIV Roivant Sciences Ltd 2023-09-28 73,031,667 11.64 850,088,604
SIOX Sio Gene Therapies Inc 2019-03-18 13,244,048 0.48 6,330,655

Holding Weightings of Svf Investments (uk) Ltd


Svf Investments (uk) Ltd Form 4 Trading Tracker

According to the SEC Form 4 filings, Svf Investments (uk) Ltd has made a total of 5 transactions in Coupang Inc (CPNG) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Coupang Inc is the sale of 46,614,154 shares on March 13, 2024, which brought Svf Investments (uk) Ltd around $895 Million.

According to the SEC Form 4 filings, Svf Investments (uk) Ltd has made a total of 1 transactions in Roivant Sciences Ltd (ROIV) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Roivant Sciences Ltd is the sale of 10,000,000 shares on September 28, 2023, which brought Svf Investments (uk) Ltd around $126 Million.

According to the SEC Form 4 filings, Svf Investments (uk) Ltd has made a total of 0 transactions in Sio Gene Therapies Inc (SIOX) over the past 5 years. The most-recent trade in Sio Gene Therapies Inc is the acquisition of 833,333 shares on March 18, 2019, which cost Svf Investments (uk) Ltd around $10 Million.

Insider Trading History of Svf Investments (uk) Ltd

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Svf Investments (uk) Ltd Trading Performance

GuruFocus tracks the stock performance after each of Svf Investments (uk) Ltd's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Svf Investments (uk) Ltd is 7.19%. GuruFocus also compares Svf Investments (uk) Ltd's trading performance to market benchmark return within the same time period. The performance of stocks bought by Svf Investments (uk) Ltd within 3 months outperforms 2 times out of 3 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Svf Investments (uk) Ltd's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Svf Investments (uk) Ltd

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 3 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) 7.28 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) 4.95 LIMIT LIMIT LIMIT LIMIT LIMIT

Svf Investments (uk) Ltd Ownership Network

Ownership Network List of Svf Investments (uk) Ltd

No Data

Ownership Network Relation of Svf Investments (uk) Ltd

Insider Network Chart

Svf Investments (uk) Ltd Owned Company Details

What does Arbutus Biopharma Corp do?

Who are the key executives at Arbutus Biopharma Corp?

Svf Investments (uk) Ltd is the 10 percent owner of Arbutus Biopharma Corp. Other key executives at Arbutus Biopharma Corp include Chief Financial Officer David C Hastings , Chief Business Officer Michael J. Mcelhaugh , and Chief Scientific Officer Michael J. Sofia .

Arbutus Biopharma Corp (ABUS) Insider Trades Summary

Over the past 18 months, Svf Investments (uk) Ltd made no insider transaction in Arbutus Biopharma Corp (ABUS). Other recent insider transactions involving Arbutus Biopharma Corp (ABUS) include a net sale of 10,164 shares made by Michael J. Mcelhaugh , a net sale of 9,982 shares made by Michael J. Sofia , and a net sale of 9,593 shares made by David C Hastings .

In summary, during the past 3 months, insiders sold 8,846 shares of Arbutus Biopharma Corp (ABUS) in total and bought 0 shares, with a net sale of 8,846 shares. During the past 18 months, 42,943 shares of Arbutus Biopharma Corp (ABUS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 42,943 shares.

Arbutus Biopharma Corp (ABUS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Arbutus Biopharma Corp Insider Transactions

No Available Data

Svf Investments (uk) Ltd Mailing Address

Above is the net worth, insider trading, and ownership report for Svf Investments (uk) Ltd. You might contact Svf Investments (uk) Ltd via mailing address: 69 Grosvenor Street, London X0 W1k3jp.